Roquefort Therapeutics (ROQ) Insider Trading & Ownership GBX 4.10 +0.15 (+3.80%) (As of 03:08 AM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider Trades Roquefort Therapeutics (LON:ROQ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage60.40%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)£102,532.26Number OfInsiders Selling(Last 3 Years)0 Get ROQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Roquefort Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROQ Insider Buying and Selling by Quarter Ad Behind the MarketsDemocrats Sold Out the American Dream - Are you ready?There's a massive housing crisis looming, and nobody on Main Street knows it yet... The Democrats sold out the American Dream - and now, millions of Americans are locked out of the housing market, forced to become "permanent renters."Click here to see exactly what you need to do >>> Roquefort Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2023Dr Darrin DisleyInsiderBuy269,935GBX 7£18,895.457/12/2023Stephen Paul WestInsiderBuy15,730GBX 6£943.806/26/2023Stephen Paul WestInsiderBuy144,117GBX 7£10,088.196/23/2023Trevor Ajanthan (Ajan) ReginaldInsiderBuy35,265GBX 7£2,468.559/26/2022Dr Darrin DisleyInsiderBuy515,913GBX 8£41,273.047/4/2022Stephen Paul WestInsiderBuy210,000GBX 9£18,9006/30/2022Stephen Paul WestInsiderBuy55,147GBX 9£4,963.231/19/2022Stephen Paul WestInsiderBuy50,000GBX 10£5,000 (Data available from 1/1/2013 forward) ROQ Insider Trading Activity - Frequently Asked Questions Who is on Roquefort Therapeutics's Insider Roster? The list of insiders at Roquefort Therapeutics includes Dr Darrin Disley, Stephen Paul West, and Trevor Ajanthan (Ajan) Reginald. Learn more on insiders at ROQ. What percentage of Roquefort Therapeutics stock is owned by insiders? 60.40% of Roquefort Therapeutics stock is owned by insiders. Learn more on ROQ's insider holdings. Which Roquefort Therapeutics insiders have been buying company stock? The following insiders have purchased ROQ shares in the last 24 months: Dr Darrin Disley (£18,895.45), Stephen Paul West (£11,031.99), and Trevor Ajanthan (Ajan) Reginald (£2,468.55). How much insider buying is happening at Roquefort Therapeutics? Insiders have purchased a total of 465,047 ROQ shares in the last 24 months for a total of £32,395.99 bought. Roquefort Therapeutics Key ExecutivesMr. Stephen Paul West B.Com (Age 52)CA, Executive Chairman Compensation: $152.9kMr. Trevor Ajanthan Reginald (Age 52)CEO & Executive Director Compensation: $305.8kProf. Martin J. Evans FRS (Age 83)Group Chief Scientific Officer & Executive Director Compensation: $100kDr. Emma MorrisHead of Pre-Clinical Research More Insider Trading Tools from MarketBeat Related Companies ONC Insider Trades BVX Insider Trades FAB Insider Trades OBD Insider Trades DEST Insider Trades RENE Insider Trades OCTP Insider Trades ONT Insider Trades GNS Insider Trades OXB Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (LON:ROQ) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ROQ Stock Alerts